Determinants of exercise adherence and maintenance for cancer survivors: Implementation of a community-based group exercise program. A qualitative feasibility study.
Cancer survivors
Exercise
Implementation
Physical activity
Quality of health care
Rehabilitation
Journal
PEC innovation
ISSN: 2772-6282
Titre abrégé: PEC Innov
Pays: Netherlands
ID NLM: 9918367980406676
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
21
04
2022
revised:
08
09
2022
accepted:
28
09
2022
medline:
22
5
2023
pubmed:
22
5
2023
entrez:
22
5
2023
Statut:
epublish
Résumé
Despite verified knowledge that physical exercise plays an important part in recovery after cancer treatment, multiple studies have shown that maintaining a physically active lifestyle after cancer is challenging. There is a need for qualitative studies to increase understanding into patient experiences and perspectives, and facilitate the design of more sustainable exercise program. This qualitative descriptive feasibility study explores experiences from the implementation of a novel four-month community-based group exercise program for cancer survivors within municipality health service after completion of rehabilitation in the specialist health care service. Fourteen cancer survivors participated in focus group interviews after completing We identified a main category, A social and supportive exercise environment promotes exercise adherence and maintenance among cancer survivors. This knowledge can be useful for further efforts to implement high quality community-based group exercise programs for cancer survivors. This study adds knowledge of survivors' experience of a novel community-based group exercise program in clinical practice and can promote the implementation of sustainable community-based exercise programs for cancer survivors.
Identifiants
pubmed: 37213720
doi: 10.1016/j.pecinn.2022.100088
pii: S2772-6282(22)00073-5
pmc: PMC10194213
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100088Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
None.
Références
Int J Behav Nutr Phys Act. 2018 Jun 7;15(1):48
pubmed: 29879993
Curr Oncol. 2018 Apr;25(2):149-162
pubmed: 29719431
J Natl Cancer Inst. 2008 May 7;100(9):630-41
pubmed: 18445825
N Engl J Med. 2018 Dec 20;379(25):2438-2450
pubmed: 30575480
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):687-99
pubmed: 24599577
Breast Cancer Res. 2018 Oct 19;20(1):124
pubmed: 30340503
Support Care Cancer. 2016 Jan;24(1):337-346
pubmed: 26066051
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420971365
pubmed: 33349064
Patient Educ Couns. 2020 Nov;103(11):2361-2367
pubmed: 32376142
Patient Educ Couns. 2017 Jul;100(7):1402-1407
pubmed: 28189469
Support Care Cancer. 2022 Jan;30(1):177-185
pubmed: 34245359
Int J Behav Nutr Phys Act. 2016 Sep 09;13(1):100
pubmed: 27612561
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420946834
pubmed: 32909467
Glob Adv Health Med. 2019 Apr 17;8:2164956119837487
pubmed: 31024755
Disabil Rehabil. 2016 Jul;38(15):1500-8
pubmed: 26694581
J Cancer Surviv. 2021 Oct;15(5):713-728
pubmed: 33128705
Epidemiol Rev. 2017 Jan 1;39(1):71-92
pubmed: 28453622
Support Care Cancer. 2019 Jan;27(1):199-208
pubmed: 29931489
J Cancer Surviv. 2020 Apr;14(2):114-134
pubmed: 31858379
Support Care Cancer. 2019 May;27(5):1729-1736
pubmed: 30136023
Support Care Cancer. 2018 Mar;26(3):685-700
pubmed: 29185105
BMC Cancer. 2017 Feb 6;17(1):103
pubmed: 28166766
Med Sci Sports Exerc. 2003 Feb;35(2):333-41
pubmed: 12569225
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1018-28
pubmed: 27340121
Cancer. 2020 Jan 1;126(9):1987-1994
pubmed: 32090322
BMC Cancer. 2021 May 30;21(1):643
pubmed: 34053445
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Curr Oncol. 2017 Aug;24(4):e290-e315
pubmed: 28874900
Acta Oncol. 2015 May;54(5):609-17
pubmed: 25751760
Qual Health Res. 2009 Jul;19(7):894-906
pubmed: 19448032
Health Educ Behav. 2004 Apr;31(2):143-64
pubmed: 15090118
J Clin Oncol. 2020 Sep 20;38(27):3161-3174
pubmed: 32673152
CA Cancer J Clin. 2019 Nov;69(6):468-484
pubmed: 31617590
J Cancer Surviv. 2019 Oct;13(5):703-712
pubmed: 31347009
Acta Oncol. 2017 Apr;56(4):618-627
pubmed: 28084890
J Cancer Surviv. 2012 Jun;6(2):219-28
pubmed: 22246463
J Adv Pract Oncol. 2016 Apr;7(3):339-342
pubmed: 29152403
Arch Phys Med Rehabil. 2017 Aug;98(8):1652-1665
pubmed: 28427925
N Z Med J. 2011 Jun 24;124(1337):77-89
pubmed: 21946880
Med Sci Sports Exerc. 2019 Jun;51(6):1252-1261
pubmed: 31095082
Support Care Cancer. 2021 Mar;29(3):1575-1583
pubmed: 32740895
BMC Cancer. 2021 Feb 17;21(1):169
pubmed: 33596859
Patient Educ Couns. 2022 Jul;105(7):2629-2631
pubmed: 35120796
Physiother Theory Pract. 2022 Jan;38(1):141-150
pubmed: 32166992
J Cancer Surviv. 2015 Jun;9(2):305-38
pubmed: 25432633
J Cancer Surviv. 2013 Jun;7(2):237-46
pubmed: 23443319
Expert Rev Anticancer Ther. 2020 Oct;20(10):865-877
pubmed: 32842816
Curr Oncol. 2022 Apr 12;29(4):2662-2680
pubmed: 35448192
J Clin Oncol. 2012 Nov 20;30(33):4155-60
pubmed: 23071230
PLoS One. 2017 Aug 14;12(8):e0182554
pubmed: 28806753
Trials. 2019 Jun 11;20(1):285
pubmed: 31186053
Health Policy. 2021 Aug;125(8):1100-1107
pubmed: 34088521
Arch Phys Med Rehabil. 2022 Mar;103(3):542-558.e10
pubmed: 34375631
BMC Health Serv Res. 2021 Apr 17;21(1):358
pubmed: 33865384
Support Care Cancer. 2019 Dec;27(12):4435-4450
pubmed: 31418074
Integr Cancer Ther. 2018 Mar;17(1):16-30
pubmed: 28008778